ORAMED PHARMACEUTICALS INC. Business Finance Contracts & Agreements

62 Contracts & Agreements

Browse by Subcategory

Equity Distribution Agreements (6 contracts)
Exchange Agreements (6)
Guarantee Agreements (1)
Loan Agreements (1)
Note Agreements (3)
Purchase Agreements (14)
Registration Rights Agreements (1)
Security Agreements (3)
Share Agreements (1)
Stock Agreements (8)
Subordination Agreement (1)
Underwriting Agreements (1)
Warrant Agreements (16)

Recent Contracts

Amended and Restated Security Agreement, dated October 8, 2024, by and among Scilex Holding Company, the Subsidiaries of Scilex Holding Company party thereto, Oramed... (Filed With SEC on October 8, 2024)
Subsidiary Guarantee Amendment, dated October 8, 2024, made by certain of Scilex Holding Company subsidiaries in favor of the holders of that certain Tranche A Note (Filed With SEC on October 8, 2024)
Subordination Agreement, dated October 8, 2024, by and among Scilex Pharmaceuticals Inc., Acquiom Agency Services LLC and other signatories thereto (Filed With SEC on October 8, 2024)
Security Agreement, dated October 8, 2024, by and among Scilex Pharmaceuticals Inc., and the purchasers signatory thereto (Filed With SEC on October 8, 2024)
Purchase and Sale Agreement, dated October 8, 2024, by and among Scilex Holding Company, Silex Pharmaceuticals Inc. and the purchasers signatory thereto (Filed With SEC on October 8, 2024)
Warrant to Purchase Common Stock, dated October 8, 2024, issued by Scilex Holding Company to the Company (Filed With SEC on October 8, 2024)
Tranche B Senior Secured Convertible Note, dated October 8, 2024, issued by Scilex Holding Company to the Company (Filed With SEC on October 8, 2024)
Securities Purchase Agreement, dated October 7, 2024, by and between Scilex Holding Company and the investors signatory thereto (Filed With SEC on October 8, 2024)
Security Agreement, dated September 21, 2023, by and among Oramed Pharmaceuticals, Acquiom Agency Services LLC, Scilex Holding Company, and certain subsidiaries of Scilex Holding... (Filed With SEC on September 26, 2023)
Subsidiary Guarantee, dated September 21, 2023, by and among Oramed Pharmaceuticals, Acquiom Agency Services LLC, Scilex Holding Company, and certain subsidiaries of Scilex... (Filed With SEC on September 26, 2023)
Registration Rights Agreement, dated September 21, 2023, by and between Oramed Pharmaceuticals Inc. and Scilex Holding Company (Filed With SEC on September 26, 2023)
Scilex Holding Company Specimen Warrant Certificate (Filed With SEC on September 26, 2023)
Warrant No. ORMP CS-5 to Purchase Common Stock of Scilex Holding Company (Filed With SEC on September 26, 2023)
Warrant No. ORMP CS-4 to Purchase Common Stock of Scilex Holding Company (Filed With SEC on September 26, 2023)
Warrant No. ORMP CS-3 to Purchase Common Stock of Scilex Holding Company (Filed With SEC on September 26, 2023)
Warrant No. ORMP CS-2 to Purchase Common Stock of Scilex Holding Company (Filed With SEC on September 26, 2023)
Warrant No. ORMP CS-1 to Purchase Common Stock of Scilex Holding Company (Filed With SEC on September 26, 2023)
Senior Secured Promissory Note, dated September 21, 2023 issued to Oramed Pharmaceuticals Inc. by Scilex Holding Company (Filed With SEC on September 26, 2023)
Securities Purchase Agreement, dated September 21, 2023 by and between Scilex Holding Company and Oramed Pharmaceuticals Inc (Filed With SEC on September 26, 2023)
Second Amendment to Stock Purchase Agreement dated as of August 21, 2023, between Oramed Pharmaceuticals Inc. and Sorrento Therapeutics, Inc (Filed With SEC on August 22, 2023)
First Amendment to Stock Purchase Agreement dated August 9, 2023, by and between Oramed Pharmaceuticals Inc. and Sorrento Therapeutics, Inc (Filed With SEC on August 10, 2023)
Senior Secured, Super-Priority Debtor-in-Possession Loan and Security Agreement dated as of August 9, 2023, among Sorrento Therapeutics, Inc., Scintilla Pharmaceuticals, Inc., the... (Filed With SEC on August 9, 2023)
Stock Purchase Agreement dated as of August 7, 2023, between Oramed Pharmaceuticals Inc. and Sorrento Therapeutics, Inc (Filed With SEC on August 9, 2023)
Oravax Stock Option Agreement (Filed With SEC on March 6, 2023)
Form of Restricted Stock Unit Notice and Restricted Stock Unit Agreement (Filed With SEC on March 6, 2023)
Form of Securities Purchase Agreement, dated as of November 3, 2021 between the Company and each Purchaser in the Offering (Filed With SEC on November 4, 2021)
Equity Distribution Agreement, dated September 1, 2021, by and between the Company and Cantor Fitzgerald & Co (Filed With SEC on September 1, 2021)
Equity Distribution Agreement, dated July 15, 2021, by and between the Company and Canaccord Genuity (Filed With SEC on July 15, 2021)
Equity Distribution Agreement, dated June 16, 2021, by and between the Company and Canaccord Genuity (Filed With SEC on June 16, 2021)
Equity Distribution Agreement, dated December 1, 2020, by and between the Company and Canaccord Genuity (Filed With SEC on December 1, 2020)
Amendment to the Equity Distribution Agreement, dated February 10, 2020, between Canaccord Genuity LLC and Oramed Pharmaceuticals Inc (Filed With SEC on April 6, 2020)
Form of Underwriters Warrant (Filed With SEC on February 28, 2020)
Underwriting Agreement, dated February 27, 2020, between Oramed Pharmaceuticals Inc. and National Securities Corporation (Filed With SEC on February 28, 2020)
Form of Notice of Stock Option Award and Stock Option Award Agreement (Filed With SEC on November 27, 2019)
Equity Distribution Agreement, dated September 5, 2019, by and between the Company and Canaccord Genuity (Filed With SEC on September 5, 2019)
Form of Securities Purchase Agreement, dated as of July 2, 2018 between the Company and each Purchaser in the Offering (Filed With SEC on July 5, 2018)
Form of Common Stock Purchase Warrant (Filed With SEC on July 5, 2018)
Clinical Research Organization Services Agreement dated February 14, 2018 and effective as of November 1, 2017, between Oramed Ltd. and Integrium, LLC. (Confidential treatment has... (Filed With SEC on April 9, 2018)
Form of Restricted Stock Unit Notice and Restricted Stock Unit Agreement between the Company and the CSO or CEO (Filed With SEC on November 29, 2017)
**Confidentialportions have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securitiesand Exchange Commission (the... (Filed With SEC on November 25, 2016)